Host-directed therapies: a potential solution to combat COVID-19.


Journal

Expert opinion on biological therapy
ISSN: 1744-7682
Titre abrégé: Expert Opin Biol Ther
Pays: England
ID NLM: 101125414

Informations de publication

Date de publication:
10 2020
Historique:
pubmed: 14 8 2020
medline: 15 9 2020
entrez: 14 8 2020
Statut: ppublish

Résumé

Coronavirus disease 2019 (COVID-19) characterized by immuno-pathological host responses including pneumonia, lymphopenia, and cytokine storm that leads to severe lung inflammation, developed in acute respiratory distress syndrome (ARDS). In the absence of an effective vaccine or any definitive cure, the use of host-directed therapies is an effective alternative and demanding treatment option in the current pandemic outbreak of COVID-19.

Identifiants

pubmed: 32783643
doi: 10.1080/14712598.2020.1807001
pmc: PMC7441763
doi:

Types de publication

Editorial

Langues

eng

Sous-ensembles de citation

IM

Pagination

1117-1120

Références

Lancet Respir Med. 2020 Apr;8(4):420-422
pubmed: 32085846
JAMA. 2020 Mar 17;323(11):1061-1069
pubmed: 32031570
Blood Transfus. 2020 May;18(3):167-169
pubmed: 32281926
Clin Infect Dis. 2020 Apr 09;:
pubmed: 32270184
Nat Rev Drug Discov. 2018 Jan;17(1):35-56
pubmed: 28935918
Lancet. 2020 Feb 22;395(10224):e35-e36
pubmed: 32035018
Travel Med Infect Dis. 2020 May 30;:101755
pubmed: 32479816
Infect Dis Clin North Am. 2019 Dec;33(4):869-889
pubmed: 31668196
Eur Respir J. 2020 Apr 16;55(4):
pubmed: 32269085
Aging Dis. 2020 Mar 9;11(2):216-228
pubmed: 32257537
Clin Microbiol Rev. 2020 Jun 24;33(4):
pubmed: 32580969
Lancet Infect Dis. 2020 Apr;20(4):400-402
pubmed: 32113509
Proc Natl Acad Sci U S A. 2020 May 19;117(20):10970-10975
pubmed: 32350134
Lancet. 2020 Feb 15;395(10223):497-506
pubmed: 31986264
J Thromb Haemost. 2020 May;18(5):1094-1099
pubmed: 32220112
Clin Chem Lab Med. 2020 Jun 25;58(7):1116-1120
pubmed: 32172226
Nat Rev Drug Discov. 2016 May;15(5):327-47
pubmed: 26868298
Lancet. 2020 Feb 15;395(10223):e30-e31
pubmed: 32032529
Lancet. 2020 May 2;395(10234):1407-1409
pubmed: 32278362
J Thromb Thrombolysis. 2020 Jul;50(1):54-67
pubmed: 32415579
Lancet Respir Med. 2020 Mar;8(3):267-276
pubmed: 32043986
Microb Pathog. 2019 May;130:156-168
pubmed: 30876870
Cell Mol Immunol. 2020 May;17(5):533-535
pubmed: 32203188
J Autoimmun. 2015 Jun;60:1-11
pubmed: 25998834
J Med Virol. 2020 Apr;92(4):424-432
pubmed: 31981224
Aging Dis. 2020 Mar 9;11(2):462-464
pubmed: 32257554
Nat Med. 2020 May;26(5):681-687
pubmed: 32327758
Science. 2020 Aug 7;369(6504):718-724
pubmed: 32661059
Clin Immunol. 2020 May;214:108393
pubmed: 32222466

Auteurs

Piyush Baindara (P)

Department of Molecular Microbiology and Immunology, University of Missouri , Columbia, MO, USA.

Sonali Agrawal (S)

Immunology Division, ICMR-National JALMA Institute for Leprosy and Other Mycobacterial Diseases , Agra, India.

Santi M Mandal (SM)

Central Research Facility, Indian Institute of Technology Kharagpur , Kharagpur, India.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH